Etrasimod efficacy in patients with mildly to moderately active ulcerative colitis (modified Mayo score 4–6) in the phase 3 ELEVATE UC clinical programme - Yarur, A J; D’Haens, G R; Baert, F; Goetsch, M; Zang, C; Gu, G; Mazur, R; Keating, M; Kudlacz, E; Sidhu, S; Wosik, K; Danese, S (Zeitschrift für Gastroenterologie, 2025)